Letter re: "Elevated serum homocysteine and McKusick's hypothesis of a disturbed collagen cross-linking: What do we really know?"

Bone

Volumn 39, Issue 6, 2006, Pages 1385-1386

  Herrmann, Markus ^a   Widmann, Thomas ^a   Herrmann, Wolfgang ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; HOMOCYSTEINE; CROSS LINKING REAGENT;

AMINO ACID BLOOD LEVEL; CROSS LINKING; DISEASE ASSOCIATION; FRAGILITY FRACTURE; HUMAN; HYPERHOMOCYSTEINEMIA; HYPOTHESIS; LETTER; AGED; BIOLOGICAL MODEL; BONE; BONE DENSITY; CHEMISTRY; FRACTURE; METABOLISM; NOTE; OSTEOPOROSIS;

AGED; BONE AND BONES; BONE DENSITY; COLLAGEN; CROSS-LINKING REAGENTS; FRACTURES, BONE; HUMANS; HYPERHOMOCYSTEINEMIA; MODELS, BIOLOGICAL; OSTEOPOROSIS;

EID: 33751543053     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2005.12.002     Document Type: Letter

References (24)

1. de Bree A., Verschuren W.M., Kromhout D., Kluijtmans L.A., and Blom H.J. Homocysteine determinants and the evidence to what extent homocysteine determines the risk of coronary heart disease. Pharmacol. Rev. 54 (2002) 599-618
2. Selhub J., Jacques P.F., Wilson P.W., Rush D., and Rosenberg I.H. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 270 (1993) 2693-2698 [see comments]
3. Herrmann W., Quast S., Ullrich M., Schultze H., Bodis M., and Geisel J. Hyperhomocysteinemia in high-aged subjects: relation of B-vitamins, folic acid, renal function and the methylenetetrahydrofolate reductase mutation. Atherosclerosis 144 (1999) 91-101
4. Stanger O., Herrmann W., Pietrzik K., Fowler B., Geisel J., Dierkes J., et al. DACH-LIGA homocystein (German, Austrian and Swiss Homocysteine Society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations. Clin. Chem. Lab. Med. 41 (2003) 1392-1403
5. Refsum H., Smith A.D., Ueland P.M., Nexo E., Clarke R., McPartlin J., et al. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin. Chem. 50 (2004) 3-32
6. McKusick V.A. Heritable disorders of connective tissue (1966), C.V. Mosby, St. Louis 155 pp.
7. Schedewie H., Willich E., Grobe H., Schmidt H., and Muller K.M. Skeletal findings in homocystinuria: a collaborative study. Pediatr. Radiol. 1 (1973) 12-23
8. Brenton D.P. Skeletal abnormalities in homocystinuria. Postgrad. Med. J. 53 (1977) 488-496
9. Lubec B., Fang-Kircher S., Lubec T., Blom H.J., and Boers G.H. Evidence for McKusick's hypothesis of deficient collagen cross-linking in patients with homocystinuria. Biochim. Biophys. Acta 1315 (1996) 159-162
10. Masse P.G., Boskey A.L., Ziv I., Hauschka P., Donovan S.M., Howell D.S., et al. Chemical and biomechanical characterization of hyperhomocysteinemic bone disease in an animal model. BMC Musculoskelet. Disord. 20 (2003) 4:2
11. Masse P.G., Rimnac C.M., Yamauchi M., Coburn S.P., Rucker R.B., Howell D.S., et al. Pyridoxine deficiency affects biomechanical properties of chick tibial bone. Bone 18 (1996) 567-574
12. van Meurs J.B., Dhonukshe-Rutten R.A., Pluijm S.M., van der Kim M., de Jonge R., Lindemans J., et al. Homocysteine levels and the risk of osteoporotic fracture. N. Engl. J. Med. 350 (2004) 2033-2041
13. McLean R.R., Jacques P.F., Selhub J., Tucker K.L., Samelson E.J., Broe K.E., et al. Homocysteine as a predictive factor for hip fracture in older persons. N. Engl. J. Med. 350 (2004) 2042-2049
14. Sato Y., Honda Y., Iwamoto J., Kanoko T., and Satoh K. Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial. JAMA 293 (2005) 1082-1088
15. Dhonukshe-Rutten R.A., Van Dusseldorp M., Schneede J., de Groot L.C., and van Staveren W.A. Low bone mineral density and bone mineral content are associated with low cobalamin status in adolescents. Eur. J. Nutr. 44 6 (2004) 341-347
16. Dhonukshe-Rutten R.A., Pluijm S.M., de Groot L.C., Lips P., Smit J.H., and van Staveren W.A. Homocysteine and vitamin B12 status relate to bone turnover markers, broadband ultrasound attenuation, and fractures in healthy elderly people. J. Bone Miner. Res. 20 (2005) 921-929
17. Morris M.S., Jacques P.F., and Selhub J. Relation between homocysteine and B-vitamin status indicators and bone mineral density in older Americans. Bone 37 (2005) 234-242
18. Herrmann M., Kraenzlin M., Pape G., Sand-Hill M., and Herrmann W. Relation of homocysteine, biochemical bone turnover markers and bone mineral density in peri- and postmenopausal women. Clin. Chem. Lab. Med. 43 (2005) 1118-1123
19. Herrmann M., Widmann T., and Herrmann W. Homocysteine-A newly recognized risk factor for osteoporosis. Clin. Chem. Lab. Med. 43 (2005) 1111-1117
20. Lees S., Eyre D.R., and Barnard S.M. BAPN dose dependence of mature crosslinking in bone matrix collagen of rabbit compact bone: corresponding variation of sonic velocity and equatorial diffraction spacing. Connect. Tissue Res. 24 (1990) 95-105
21. Raposo B., Rodriguez C., Martinez-Gonzalez J., and Badimon L. High levels of homocysteine inhibit lysyl oxidase (LOX) and downregulate LOX expression in vascular endothelial cells. Atherosclerosis 177 (2004) 1-8
22. Hill C.H., Mecham R., and Starcher B. Fibrillin-2 defects impair elastic fiber assembly in a homocysteinemic chick model. J. Nutr. 132 (2002) 2143-2150
23. Liu G., Nellaiappan K., and Kagan H.M. Irreversible inhibition of lysyl oxidase by homocysteine thiolactone and its selenium and oxygen analogues. Implications for homocystinuria. J. Biol. Chem. 272 (1997) 32370-32377
24. Levene C.I., Sharman D.F., and Callingham B.A. Inhibition of chick embryo lysyl oxidase by various lathyrogens and the antagonistic effect of pyridoxal. Int. J. Exp. Pathol. 73 (1992) 613-624